New anxiety drug tested on brain and behavior
NCT ID NCT07478744
Summary
This study is testing a single dose of an investigational drug called SYT-510 for people with generalized anxiety disorder (GAD). It aims to see how the drug affects brain activity, anxiety-related behaviors, and feelings of dread in 24 unmedicated adults. The main goal is to gather information to help design future, larger studies for anxiety treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.